Correction: Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4488309?pdf=render |
Similar Items
-
Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
by: Joost C M Uitdehaag, et al.
Published: (2015-01-01) -
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
by: Hang Ruan, et al.
Published: (2022-03-01) -
Correction: EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model?
by: PLOS ONE Staff
Published: (2015-01-01) -
Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
by: PLOS ONE Staff
Published: (2021-01-01) -
Correction: The environmental consequences of climate-driven agricultural frontiers.
by: PLOS ONE Staff
Published: (2020-01-01)